Differences in pharmacokinetics and hepatobiliary transport of a novel anti-inflammatory agent between normal and adjuvant arthritis rats

References

• ACHIRA, M., TOTSUKA, R., FUJIMURA, H. and KUME, T., 2002, Tissue-specific regulation of P-glycoprotein in adjuvant arthritis rats. European Journal of Pharmaceutical Science, 16, 29–36.
   PubMedGoogle Scholar
• ACHIRA, M., TOTSUKA, R., FUJIMURA, H. and KUME, T.YOSHIKAWA, M., 2000, Effect of adjuvant arthritis on the activity of the P-glycoprotein in the liver. Paper presented at the Annual Meeting of Japanese Society for the Study of Xenobiotics.
   Google Scholar
• BELPAIRE, F. M., SMET, F. DE, CHINDAVIJAK, B., FRAEYMAN, N. and BOGAERT, M. G., 1989, Effect of turpentine-induced inflammation on the disposition kinetics of propranolol, metoprolol and antipyrine in the rat. Fundamental of Clinical Pharmacology, 3, 79–88.
   PubMed Web of Science ®Google Scholar
• BISHOP, H., SCHNEIDER, R. E. and WELLING, P., 1981, Plasma propranolol concentrations in rats with adjuvant-induced arthritis. Biopharmakinetics and Drug Disposition, 2, 291–297.
   PubMed Web of Science ®Google Scholar
• BOOTH, C. L., BROUWER, K. R. and BROUWER, K. L. R., 1998, Effect of multidrug resistance modulators on the hepatobiliary disposition of doxorubicin in the isolated perfused rat liver. Cancer Research, 58, 3641–3648.
   PubMed Web of Science ®Google Scholar
• BORSELLINO, N., CRESCIMANNO, M., FLANDINA, C., FLUGY, A. and D'ALESSANDRO, N., 1994, Combined activity of interleukin-lalpha or TNF-alpha and doxorubicin on multidrug resistant cell lines: evidence that TNF and DXR have synergistic antitumor and differentiation-inducing effects. Anticancer Research, 14, 2643–2548.
   Google Scholar
• BUCHAR, E. and JANKU, I., 1985, The effect of adjuvant-induced arthritis on rat liver microsomal phospholipid metabolism. Methods and Findings in Experimental and Clinical Pharmacology, 7, 469–472.
   PubMedGoogle Scholar
• DIPASQUALE, G., WELAJ, P. and RASSAERT, C. L., 1974, Prolonged pentobarbital sleeping time in adjuvant-induced polyarthritic rats. Research Communications in Chemical Pathology and Pharmacology, 9, 253–264.
   PubMedGoogle Scholar
• GOMI, J., AOYAGI, T., OANA, M., MITSUNO, Y., KAWAI, T., YAMADA, Y. and YAMADA, Y., 1969, Studies on flucloxacillin binding rate and capacity to horse serum protein. Chemotherapy, 17, 1363–1366.
   Google Scholar
• HARRIS, E. D., 1981, Rheumatoid arthritis; the clinical spectrum. In Textbook of Rheumatology (Philadelphia: W. B. Saunders), pp. 928–963.
   Google Scholar
• HUNTER, J., HIRST, B. H. and SIMMONS, N. L., 1993, Drug absorption limited by P-glycoprotein-mediated secretory drug transport in human intestinal epithelial Caco-2 cell layers. Pharmacology Research, 10, 743–742.
   PubMed Web of Science ®Google Scholar
• KATO, Y., YAMAZAKI, M. and SUGIYAMA, Y., 2000, Biliary excretion. In Sohgo Seizaigaku (Tokyo: Nanzando), pp. 112–128.
   Google Scholar
• LIN, J. H. SUGIYAMA, Y., AWAZU, S. and HANANO, M., 1982, In vitro and in vivo evaluation of the tissue-to-blood partition coefficient for physiological pharmacokinetic models. Journal of Pharmacokinetics and Biopharmacology, 10, 637–647.
   PubMedGoogle Scholar
• MASUDA, M., IIZUKA, Y., YAMAZAKI, M., NISHIGAKI, R., KATO, Y., NeINUMA, K., SUZUKI, H. and SUGIYAMA, Y., 1997, Methotrexate is excreted into the bile by canalicular multispecific organic anion transporter in rats. Cancer Research, 57, 3506–3510.
   PubMed Web of Science ®Google Scholar
• MEUNIER, C. J. and VERBEECK, R. K., 1999, Glucuronidation of R- and S-ketoprofen, acetoaminophen, and diflunisal by liver microsomes of adjuvant-induced arthritic rats. Drug Metabolism and Disposition, 27, 26–31.
   PubMed Web of Science ®Google Scholar
• NAKAMURA, J., NISHIDA, T., HAYASHI, K., KAWADA, N., UESHIMA, S., SUGIYAMA, Y., ITo, T., SOBUE, K. and MATSUDA, FL, 1999, Kupffer cell-mediated down regulation of rat hepatic cMOAT/MRP2 gene expression. Biochemical and Biophysical Research Communications, 255, 143–149.
   PubMed Web of Science ®Google Scholar
• PHILIPPE, L., GEGOUT-POTTIE, P., GUINGAMP, C., BORDJI, K., TERLAIN, B., NETTER, P. and GILLET, P., 1997, Relations between functional, inflammatory, and degenerative parameters during adjuvant arthritis in rats. American Journal of Physiology, 273, R1550—R1556.
   Google Scholar
• PIQUETTE-MILLER, M. and JAMALI, F., 1992, Effect of adjuvant arthritis on the disposition of acebutolol enantiomer in rats. Agent Actions, 37, 290–296.
   PubMedGoogle Scholar
• PIQUETTE-MILLER, M. and JAMALI, F., 1993, Selective effect of adjuvant arthritis on the disposition of propranolol enantiomer in rats detected using a stereospecific HPLC assay. Pharmacology Research, 19, 294–299.
   Google Scholar
• PIQUETTE-MILLER, M., PAK, A., KIM, H., ANART, R. and SHANHZAMANT I, A., 1998, Decreased expression and activity of P-glycoprotein in rat liver during acute inflammation. Pharmacology Research, 15, 706–711.
   PubMed Web of Science ®Google Scholar
• SCHNEIDER, R. E, BISHOP, H. and HAWKINS, C. F., 1979, Plasma propranolol concentrations and the erythrocyte sedimentation rate. British journal of Clinical Pharmacology, 8, 43–47.
   PubMed Web of Science ®Google Scholar
• SHIBATA, N., SHIMAKAWA, H., MINOUCHI, T. and YAMAJI, A., 1993, Pharmacokinetics of cyclosporin A after intravenous administration to rats in various disease states. Biology and Pharmacology Bulletin, 16, 1130–1135.
   PubMed Web of Science ®Google Scholar
• SU, S. F. and HUANG, J. D., 1996, Inhibition of the intestinal digoxin absorption and exsorption by quinidine. Drug Metabolism and Disposition, 24, 142–147.
   PubMed Web of Science ®Google Scholar
• TERAO, T., HISANAGA, E., SAL, Y., TAMAI, I. and Tsun, A., 1996, Active secretion of drugs from the small intestinal epithelium in rats by P-glycoprotein functioning as an absorption barrier. journal of Pharmaceutics and Pharmacology, 48, 1083–1089.
   PubMed Web of Science ®Google Scholar
• TODA, A., Ismi, N., KIHARA, T., NAGAMATSU, A. and SHIMENO, H., 1994, Effects of adjuvant-induced arthritis on hepatic drug metabolism in rats. Xenobiotica, 26, 603–611.
   Google Scholar
• VARGA, A., NUGEL, H., BAEHR, R., MARX, U., HEVBR, A., NACSA, J., OCSOVSZKY, I. and MOLNAR, J., 1996, Reversal of multidrug resistance by amitriptyline in vitro. Anticancer Research, 16, 209–212.
   PubMed Web of Science ®Google Scholar
• WILLIAMS, R. O., FELDMANN, M. and MAINI, R. N., 1992, Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proceedings of the National Academy of Sciences, USA, 89, 9784–9788.
   PubMed Web of Science ®Google Scholar
• YASUHARA, M., FUJIWARA, J., KITADE, S., KATAYAMA, H., OKUMURA, K. and HORI, R., 1985, Effect of altered plasma protein on pharmacokinetics and pharmacodynamics of propranolol in rats after surgery. Journal of Pharmacology and Experimental Therapeutics, 235, 513–520.
   PubMed Web of Science ®Google Scholar